Showing results (661-670 of 791) with videos related to
Sort By:
Pageof 80
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 1, 2013
Shining a light on posterior cortical atrophySebastian J Crutch, Jonathan M Schott, Gil D Rabinovici, et al.Neuroimage. Clinical|June 12, 2021
Cross-cohort generalizability of deep and conventional machine learning for MRI-based diagnosis and prediction of Alzheimer's diseaseEsther E Bron, Stefan Klein, Janne M Papma, et al.Annals of Clinical Biochemistry|April 4, 2009
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's diseaseN A Verwey, W M van der Flier, K Blennow, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 6, 2019
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotypeLisa Vermunt, Sietske A M Sikkes, Ardo van den Hout, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 21, 2012
Impact of molecular imaging on the diagnostic process in a memory clinicRik Ossenkoppele, Niels D Prins, Yolande A L Pijnenburg, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 5, 2020
Circulating metabolites are associated with brain atrophy and white matter hyperintensitiesFrancisca A de Leeuw, Hata Karamujić-Čomić, Betty M Tijms, et al.Alzheimer'S Research & Therapy|May 12, 2023
The reporting of neuropsychiatric symptoms in electronic health records of individuals with Alzheimer's disease: a natural language processing studyWillem S Eikelboom, Ellen H Singleton, Esther van den Berg, et al.Alzheimer'S Research & Therapy|August 21, 2024
Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer's disease pathology in the eye clinicIlse Bader, Colin Groot, H Stevie Tan, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 9, 2019
Computer-assisted prediction of clinical progression in the earliest stages of ADHanneke F M Rhodius-Meester, Hilkka Liedes, Juha Koikkalainen, et al.Molecular Neurodegeneration|June 20, 2020
Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approachInger van Steenoven, Marleen J A Koel-Simmelink, Leonie J M Vergouw, et al.Pageof 80